June 24, 2004
TABLE OF
CONTENTS
Foreword
FOREWORD by
PHILIPPE BUSQUIN
Plants have always been the most important resource for
humankind, not only for food and feed, but also for other
important biomaterials, such as oils, fibres, energy, and wood
for building houses and ships. Plant cells produce biomass from
simple chemical building blocks in the air and the soil,
including carbon dioxide, nitrogen and water, using the sun as a
‘for-free’ energy source. The cultivation of plants some 10 000
years ago can be seen as the starting point of modern
civilisation. The exploitation of plant-based fossil resources –
such as petroleum, gas or coal – made the industrial revolution
possible in the 19th century, and led to the creation
of the chemical industry in the 20th century.
Today, in the face of important challenges at the European and
global levels, we must pay renewed attention to plants. A
growing world population has to be fed, and increasing demands
for high-quality, safe and affordable food have to be met.
Fossil resources – limited in availability and a major source of
greenhouse gas emissions threatening our climate and our health
– will need to be replaced with renewable resources. The
transition to a sustainable economy based largely on renewable
resources – the ‘bio-based’ economy – is as inevitable as it is
desirable.
Scientific and technological progress, especially in plant
biotechnology and genomics, will have to play a role in
achieving this transition , in particular under the constraints
of limited availability of arable
land, climate change and increased seasonal weather instability.
Biotechnology can help to breed plants that are more drought
resistant and stress tolerant, and to increase agricultural
productivity, while reducing such inputs as fertilisers,
pesticides and water to ensure long-term sustainability.
Europe’s scientific and technological capabilities will also
strongly determine the competitiveness of some of its largest
industries. This concerns the agro-food industry in the first
place, with more than €600 billion in annual turnover, is the
leading industrial sector in the EU. But it is also important
for the chemical and energy industries. Our S&T capacity will
likely change the face of agricultural production, which employs
8% of the EU25 workforce and counts 17 million farms.
Maintaining and strengthening our scientific and technological
basis is of critical importance. We need to become an incubator
for top researchers and innovative companies, who are often
tempted to develop their activity elsewhere. This is not the
task of one organisation or of one country. It is only through
the commitment of all stakeholders, working together in a
coherent fashion at the European level, that we will be able to
address these challenges.
For this reason, I very much welcome the Plants for the
Future vision paper. The goals it sets out are very much in
line with the EU’s objectives of becoming the most competitive
and sustainable knowledge-based economy by 2010. The March 2003
European Council explicitly called for the strengthening of the
European research and innovation area to the benefit of all in
an enlarged Europe by creating technology platforms bringing
together all relevant stakeholders – including researchers,
industry, regulators and financial institutions – to develop a
strategic agenda for leading technologies, among them plant
genomics.
This vision paper is an early milestone towards realising this
recommendation. The Plants for the Future technology
platform – comprising an Advisory Council and working groups,
open to the stakeholders supporting this vision paper, Member
States and other interested partners and experts – will be
established within the coming months with the goal of delivering
a strategic research agenda by the end of this year.
I would like to thank the entire group of personalities that are
supporting this vision and the behind-the-scenes team who
drafted it and shepherded it through its various stages of
evolution. Its implementation will depend on the continuing
involvement and commitment of all stakeholders and the effective
coordination of all instruments and available resources,
including Community programmes, to achieve a critical mass in
terms of financial, scientific and technological resources.
I wish the technology platform every success. Europe needs it.
Philippe Busquin
European Commissioner for Research
Disclaimer
This vision has been drawn up through a collaborative effort
by a group of experts (the Genval Group) and endorsed by the
Group of Personalities representing various stakeholders (see
page XX). It is neither exhaustive nor comprehensive and
covers only selected aspects of broader issues. The vision,
views and information expressed in this document are those of
the group as a whole and do not necessarily reflect the
opinions of any single member, their organisations, or of the
European Commission. Neither the signatories nor the European
Commission is responsible for the use which might be made of
the information contained in this publication.
This vision paper suggests the creation of a technology
platform called Plants for the Future. The goal of this
platform is to bring together representatives of all
interested stakeholders – including scientists, industry,
consumers, environmental organisations, regulatory bodies,
political decision- and policy-makers at EU, national and
regional level, and other interested stakeholders – to
co-operate pragmatically to refine this vision, to identify
strategic priorities, and to define and support the
implementation of a coherent and dynamic research agenda.
GROUP OF PERSONALITIES
Philippe
BUSQUIN,
EU Research Commissioner
Feike SIJBESMA, President of EuropaBio, DSM board member
Marc ZABEAU, President of the European Plant Science
Organisation, EPSO
Jim MURRAY, Director of BEUC
Mohamed H.A. HASSAN, Executive Director of the Third
World Academy of Sciences
Federico MAYOR, former Director-General of UNESCO,
Autonomous University of Madrid, President of the Foundation for
a Culture of Peace (ES)
Jean MARTIN, President of CIAA
Eggert VOSCHERAU, President of Cefic, Vice-chair of the
Board at BASF
Jochen WULFF, former CEO of Bayer CropScience
Pierre PAGESSE, Presidium Member of COGECA,
President of Limagrain (FR)
Ricardo SERRA ARIAS, Vice-President of COPA,
Vice-President of ASAJA (ES)
Sten MOBERG, President of the European Seed Association,
CEO Svalöf Weibull Seed Group (SE)
Andrzej LEGOCKI, President of the Academy of Sciences,
Poland
Richard B FLAVELL, CSO of Ceres, former Director of John
Innes Centre
Christiane NÜSSLEIN-VOLHARD, German Nobel Prize laureate
Peter GRUSS, President Max Planck Society (DE)
Tim HUNT, UK Nobel Prize laureate
Julia GOODFELLOW, CEO BBSRC (UK)
Marion GUILLOU, Director-General of INRA (FR)
Peter FOLSTAR, Director of the Netherlands Genomics
Initiative and coordinator of ERA-NET Plant Genomics
EXECUTIVE SUMMARY
Since time immemorial, plants have been crucial to our survival
and prosperity. From the world’s first ‘green revolution’ – the
invention of agriculture – in the Middle East, to today’s
high-tech agribusiness, plants have been at the centre of our
diets, economy and much more.
Plants are not only our food and fodder for animals but we also
use them to make clothes, paper, paints, oils, medicines, and
biodegradable plastics, among many other things. We all know
that money does not grow on trees, but plants are a big part of
our economic prosperity. The agro-food industry in the EU
represents a €600 billion annual turnover, utilising a fifth of
the Union’s land. It is the continent’s third largest employer,
with 2.6 million jobs – excluding farmers – mainly in small to
medium-sized enterprises (SMEs). The European food and drinks
industry transforms more than 70% of the agricultural raw
materials produced in the EU and exports in excess of €45
billion. Forestry and its related industries employ more than
3.5 million Europeans and contribute more than €200 billion to
the EU economy (1).
We have come a long way since a 19th century
Augustinian monk named Gregor Mendel found in plants that
biological traits were passed on from one generation to the next
by discrete ‘factors’. Now known as ‘genes’, they form the basis
for the scientific study of genetics upon which a growing part
of modern science, medicine and technology is based. In the half
century since the double helix structure of DNA – the ‘king of
molecules’ and building block of genes which transmits genetic,
or hereditary, information from parents to their offspring – was
discovered, our understanding of the life sciences has
progressed in leaps and bounds. Scientists have already
painstakingly mapped out the entire human genome – the billions
of sequences of
DNA
that constitute the genetic make up of our bodies. Although the
exact functions of many of these strands is still not known, our
growing knowledge of the molecular mechanics of organisms will
one day yield vast health rewards. Genomics and biotechnology
hold great promise of uncovering effective treatments for health
problems.
Scientific investigation of the genome has not been limited to
humans, but encompasses many other animal and plant species.
Although the focus of research has tended towards human
genomics, investing more in researching plant genomics will pay
potentially huge dividends. The EU has long been a trailblazer
in this area. Europe, for instance, was a key member of the
international team which mapped out the first complete plant
genetic sequence – that of Arabidopsis (a genus of the mustard
family). Our expanding knowledge of the genetic make up of
plants could dramatically change our approach to agriculture.
Genetics will continue to pave the way to increasing
agricultural yields, lowering our dependence on fertilisers,
making crops more resistant to diseases, and more. In addition,
we are now aware that we are taking advantage of only a small
fraction of Nature’s genetic diversity. There are enormous
opportunities to use plants much more effectively to meet the
challenges and demands facing European society in an
environmentally friendly and sustainable way. Europe possesses a
unique geographic and climatic diversity, a tremendous wealth of
cultivated and undomesticated plant species, and long-standing
plant breeding experience. Europe should build on the excellence
it has achieved in this area by promoting new initiatives to
make the most of this vital natural resource. Plant-based oils,
lubricants, fibres and polymers – which, unlike synthetic
plastics, can be broken down quickly by natural processes –
could help to slash pollution.
However, Europe’s research and development (R&D) efforts have so
far been fragmented and have suffered from the lack of a
coherent strategic vision. Regional, national and European
research programmes, as well as public-private R&D partnerships,
have not delivered enough successful applications or spin-offs.
The EU’s ambition is to build the world’s most competitive
knowledge-based economy. One important outlet for this
cutting-edge knowledge should be what may be referred to as the
‘bio-based economy’. Given the importance of the sector, the
consequences for Europe of failing to act could be dramatic. We
urgently need to place the European agricultural, forestry and
food industries on more competitive ground – founded on a
scientifically and ethically sound science and technology base
– and enhance its ability to underwrite global food security and
create new bio-based products.
The future competitiveness of Europe’s agricultural and food
processing industries will depend on plant genomics,
biotechnology and their smart application. These areas are
developing rapidly around the world, and Europe risks losing the
competitive edge it once possessed as the mantle of innovation
passes to the United States. Investments in plant biotechnology
in Canada, Asia, India and South America are also accelerating
rapidly as these countries seek to solve their food security
problems and to capture a bigger share of agricultural trade. In
contrast, Europe's position is declining as a consequence of the
political inertia caused by the polarised and increasingly
heated debate between opponents and advocates, with a sceptical
and confused public caught in the crossfire.
If Europe is not to fall behind its major global competitors in
this crucial area of innovation and future prosperity, the
legitimate concerns of both critics and advocates need to be
addressed. For instance, risk assessments carried out in recent
years have uncovered no adverse health effects from genetically
modified (GM) crops. We need to take a more holistic approach –
used as part of a broader system, modern biotechnology can be a
helpful addition to our current agricultural mix, although their
misapplication could potentially have some adverse health and
environmental effects Europe should proceed responsibly in
developing biotechnologies while minimising any adverse effects.
The future is, of course, uncertain. Plant genomics and
biotechnology is neither a magic wand that will wave away all
our problems nor will it wreak havoc and disaster. To fully
appreciate the potential benefits and pitfalls, and to chart a
safe course through them, requires a publicly supported road
map. That is the purpose behind the proposed creation of the
Plants for the Future – tapping the potential of plant
technology platform. There will undoubtedly be successes and
set backs, but the potential rewards for our health and
prosperity are too great for us to take a ‘wait and see’
approach.
Visionary platform
Plants for the Future
will bring together all relevant stakeholders: researchers,
policy-makers, environmental and consumer groups, industry, and
farmers. These partners will co-operate in a pragmatic,
non-dogmatic manner to reach a consensus on common priorities
and draw up action plans to implement them.
This will be a challenging task but the payoff for sharing and
acting upon a common vision could be enormous: a competitive,
independent and sustainable bio-based European economy that will
address the specific needs and choices of European consumers not
only in terms of agriculture and food, but through applications
in a wide range of fields, including plant-based
pharmaceuticals, chemicals and energy.
The aims of this platform would be to suggest ways of (see
chapter four for full details):
·
Securing a high quality, safe and diverse food supply for
European consumers
·
Creating a sustainable European agricultural base for the
production of food and feed, as well as other renewable,
bio-based products
·
Strengthening the competitiveness of the European agri-food
sector to ensure a strong domestic European food supply and
consumer choice
The platform proposes that these goals can be reached by:
·
Promoting societal consensus based on a mutual understanding and
communications between stakeholders
·
Suggesting a coherent legal framework for the sector’s
development
·
Boosting public and private R&D investment and enhancing the
transparency of European research at regional, national and
European level
·
Strengthening industry support for the platform’s research
agenda
·
Developing a pertinent strategic research agenda – based on the
identification of the sector’s priorities – pursuing a
multidisciplinary approach covering such areas as genomics,
physiology, agronomy, ecology, bioinformatics and other emerging
skills.
Sowing the seeds of modern civilisation
Plants form the basis for almost all
life on Earth, as living organisms in their own right or as food
for animals. By catching solar energy, unlike animals, they
actually add to the Earth’s net store of energy. The
unique process of photosynthesis which converts atmospheric
carbon dioxide, the main ‘greenhouse gas’, into carbohydrates
via a solar energy-driven process produces the biomass needed by
most living organisms.
When people first started cultivating plants in the Middle East
some ten thousand years ago, it profoundly altered their way of
life. With the birth of agriculture, humanity moved away from
the hand-to-mouth existence of the hunter-gatherer and was able
to store food for leaner times. No longer needing to chase their
food, people were able to abandon nomadic life and live in
settled communities, sowing the seed for modern civilisation.
Today, plants are used not only as food for humans and feed for
cattle, but as industrial raw materials. They are also valuable
sources of vitamins, antioxidants, oils, fibres and
carbohydrates. They provide the ingredients for most drugs and
are a major traditional energy resource. The petroleum that
keeps modern society ticking is also of plant origin, while
modern biofuels promise to reduce the pollution caused by fossil
fuels.
Rising populations and living standards are not only straining
the world’s food production capacity, they have led to the
increasing use of non-renewable resources and synthetic
materials, such as plastics (a petroleum product). This has
meant that more greenhouse gases – such as carbon dioxide – are
being pumped into the atmosphere, contributing to climate
change. It has also meant that the world is producing waste
faster than the Earth can break it down. Environmental concerns
and finite supplies of fossil fuels are making biomaterials –
which can be broken down easily by natural forces – and biofuels
attractive alternatives.
Green economics
The economic importance of plants and plant-derived products in
Europe is huge in terms of turnover of associated industries,
employment and trade:
·
The European seed market, worth €8.4 billion annually, is the
largest regional market (30% of the global market)
·
Europe carved out a 28% share of the €26.6 billion global
agrochemical market in 2003
·
European forestry and its related industries employ more than
3.5 million people with an annual turnover of over €200 billion
·
There are nearly 7 million farms, with an average size of 18.4
hectares and employing nearly 15 million people, in the 15 older
EU Member States (EU15). With enlargement, the number of farms
has more than doubled to 17 million, and the proportion of
farmers in the workforce has grown from around 4% (EU15) to
nearly 8% (EU25)
·
Livestock production in Europe consumes 400 million tonnes of
feed, including grazing land, of which 90% is produced in Europe
·
The EU imports €66.6 billion worth of agricultural products and
exports €55.7 billion
·
The European food and drink industry is the leading EU
industrial sector with over €600 billion of production and €145
billion of added value. With 2.6 million workers, it is the
Union’s third largest employer
·
Europe currently accounts for only 10% of the fast-growing
markets for crop-derived fibres and raw materials, which
increased globally from 50.9 to 70 million tonnes over the past
five years
Plant genomics and biotechnology
Genomics and biotechnology are the modern tools for
understanding plants at the various biological and environmental
levels, as well as boosting classical plant breeding techniques.
An array of novel technologies have emerged that are now
permitting researchers to identify the genetic underpinnings of
crop improvement, namely the genes that contribute to the
improved productivity and quality of modern crop varieties.
The much-debated genetic modification (GM) of plants is one of
the biotechnologies used, depending on the specific challenges
to be addressed, but we should not make the fundamental mistake
of equating agricultural and plant biotechnology with GM alone.
Genetic modification of plants is not the only technology in the
toolbox of modern plant biotechnologies.
Application of these technologies will substantially improve
plant breeding, farming and food processing. In particular, the
new technologies will enhance our ability to improve crops
further and, not only make them more traceable, but also enable
different varieties to exist side by side (known as crop
co-existence) – enhancing the consumer’s freedom to choose
between conventional, organic and GM food. Taking advantage of
the genetic diversity of plants will not only give consumers a
wider choice of food, but it will also expand the range of
plant-derived products, including novel forms of
pharmaceuticals, biodegradable plastics, bio-energy, paper, and
more.
Plant genomics and biotechnology could potentially transform
agriculture into a more knowledge-based business. This could
strengthen the sector’s sustainability and profitability by
reducing uncertainty and the dependence of farmers on variable
ecological and climatic conditions. Critics fear that modifying
the genetic make up of some plants could lead to the possible
emergence of such complications as ‘superweeds’ or toxic food.
Although scientific investigation in new fields is never
risk-free, with due scientific precaution and diligence,
constant and careful monitoring, and strict regulation, adverse
developments can be prevented.
A strong European science and industry base in this important
sector will allow Europe to address a number of socio-economic
challenges:
·
Securing a healthy and safe food supply
Improving living standards, particularly in developed countries,
and a growing world population are rapidly boosting global
demand for high quality and safe food. Food shortages and
famines are currently localised phenomena and can be addressed
by improving the distribution of the world’s food output.
However, as the globe’s 6 billion inhabitants climb to more than
9 billion over the next half century, not only will this mean
there are more mouths to feed but there will be less arable land
with which to do it. This means that food distribution will have
to become more equitable and farming will need to become both
more productive and diversified. In addition, to respond to
consumer expectations, the quality of plants has to be improved
and their nutritional value boosted.
·
Sustainable agriculture
We urgently need to make today’s chemical-intensive agriculture
more sustainable while maintaining its productivity. In fact, we
need to increase yields and simultaneously reduce or optimise
the amount of fuel, fertilisers, pesticides and water used up in
the process. The dual challenges of global climate changes and
increased seasonal weather instabilities are placing additional
strains on the world’s agricultural capacity, particularly as
more marginal land is farmed.
·
Green and pleasant land
Agricultural waste can be reduced to a minimum through the
efficient use of bio-waste to produce biomaterials and
bio-energy. As we run down our supplies of fossil fuels and
their environmental impact grows, we will need to substitute
them with renewable and environmentally friendly fuel sources.
In addition, efficient land management will become increasingly
necessary to ensure diversity of agricultural production,
protection of the environment and conservation of natural
resources and biodiversity.
·
Competitiveness and consumer choice
A competitive global position for the EU in agriculture,
biotechnology and food production will benefit employment and
economic growth across the Union. Developing new technologies
and agricultural products can help the environment and have a
positive impact on rural development. In addition, it would
ensure a strong domestic and sustainable European food supply
offering consumers a wide choice of healthy and diverse food.
Picking the fruits of the bio-economy
A time traveller to 2025 might find that the bio-based economy
that has emerged has helped to confront some of the major
challenges facing Europe and humanity as a whole. Below are
some of the features of that future world.
The seeds of wealth
It is said that money does not grow on trees, but more of our
economic prosperity in 2025 will be based on agricultural
produce. Not only will farmers grow food for a larger
population, but much of the economy will also be based on the
raw materials they grow: new foods, biofuels, and
biomaterials. They will become the gatekeepers of the
bio-based economy.
Developing green fingers
The premium on agricultural land and exciting investment
prospects in the valuable raw materials it produces will help
reinvigorate the farming sector and provide new opportunities
in an enlarged Europe.
Escape to the country
With the attractive careers and investment prospects, farming
and its spin offs will trigger a migration away from the
cities and back to the countryside. This new agricultural
class will make up the backbone of a prosperous and lively
rural community away from the stress of urban life.
Futuristic diets
It has long been said that you are what you eat. Medical
research will have identified exactly how our diets affect
health. The knowledge this scientific insight brings will mean
that breeding by design will be used to create novel food
crops which are optimised to reduce the negative side effects
of certain types of food and offer balanced nutritional value.
The right reaction
Plant genomics may also have unlocked the secrets of how
allergic reactions to plants – such as hay fever and food
allergies – work, unearthing ways of halting this growing
problem.
Consumer connoisseurs
As more wild plants are cultivated and new food products are
created, culinary culture will witness an unprecedented
renaissance. Consumers will have a bountiful choice of tasty
fruit and vegetables with good shelf life. As enjoying and
experimenting with good food becomes an important part of
culture, interest in junk food will wane.
Vintage toast
Europeans will need their fine wine to accompany their tasty
diet. By 2025, the European wine industry will be
progressively facing up to the challenges posed by climate
change and volatile weather patterns. ‘Old world wines’ will
be in the process of combining classic subtleties with
consistent taste-filled vintages.
The right chemistry
As we run down our fossil fuel stocks and environmental
concerns grow, chemicals and fuels extracted from plants will
become – along with other renewable resources – much more
important. By 2025, we will see the emergence of sophisticated
green chemical, biodegradable polymers and biofuels. These
will help Europe meet its emissions obligations, create a more
sustainable environment and improve EU citizens’ quality of
life.
The best
medicine
The plant kingdom already offers the raw material for many
drugs. By 2025, our understanding of the genetic make up of a
larger pool of plant species will help researchers create
medicines – in particular, medical treatments tailored to the
specific needs of individual patients – to tackle many of the
major diseases we have to contend with today.
Developing capacity
Agriculture in developing countries will become more
productive, competitive and sustainable. This will be
particularly essential in view of the exponential growth in
food demand in East Asia. Higher and better yields in these
countries, and exports from Europe and North America, will be
essential to meeting fast-growing demand in China.
CHAPTER 2 -
BETWEEN PROSPERITY AND PARADOX
Europe
has been at the forefront of plant genomics and biotechnology
R&D. However, its leading position is deteriorating on the back
of public concern over the health and environmental impact of
these new technologies. This political controversy and
regulatory inertia threatens the EU’s ability to reap the
rewards of this research and puts the Union at risk of falling
further behind its main global competitors, mainly the USA and
Japan. Europe is in danger of creating another ‘European
paradox’ – as occurred with semiconductors and computer
technologies – in which it is unable to capitalise on an
excellent science and technology base by bringing innovative
products to market.
New sciences and emerging technologies always present a
challenging array of scientific and moral uncertainties. Neither
sceptics nor advocates can be absolutely certain what the
long-term biological and environmental impact of genetic
modification will be. However, more than fifteen years of close
monitoring and testing have so far uncovered no adverse effects
to the environment or human health. Nevertheless, there are many
Europeans who remain sceptical of the benefits that genetic
modification can deliver or who, for perceived quality reasons,
prefer conventional or organic foods. They have an
unquestionable right to have access to the food they wish to
consume. This means that the EU must ensure that GM,
conventional and organic crops can be grown side by side using a
balanced approach that neither prevents nor favours any of them.
The ethical dilemmas are harder to pin down and resolve.
Questions of how far we can and should go in reconfiguring the
natural order – some might call it ‘tampering with’ others may
describe it as ‘exploiting’ nature’s genetic pool – are never
easy to answer. Opinions on what is and what is not morally
acceptable vary widely and there are grey areas where few would
be willing to offer a hard and fast judgement. In fact, EU
surveys show that many Europeans would support the cautious
development of such potentially beneficial fields. Ethical
studies have also emphasised the “moral imperative” of making
these technologies available to the developing countries that
want them.
Europeans should not lose sight of the enormous social, economic
and environmental rewards of this cutting-edge field. With
appropriate regulatory and scientific controls in place, the EU
can draw maximum benefit out of these new technologies while
avoiding the potential environmental and ethical pitfalls. This
can only be achieved through a mature and sober public debate
that weighs up all the pros and cons to help chart an optimal
course forward.
Food for thought
The last three decades have seen radical changes to our diet as
consumers enjoy an unprecedented variety of high quality,
inexpensive local and imported food all year round. In terms of
plant science, many of these improvements are based on crop
breeding and genetics developed in the 1950s to 1970s. As a
means of building on this scientific and technological base,
both at EU and national level, the European Commission has
funded plant genomics and biotechnology R&D under successive
research programmes since 1982.
Early recognition of the need for investment in crop
biotechnology and genomics by EU and national funding agencies
has led to the establishment of Centres of Excellence in
universities and research institutes, and the development of new
platform technologies and research breakthroughs by the European
research community. The Union is home to a number of pioneering
SMEs, such as Plant Genetics Systems (PGS), Mogen, and Keygene.
Newer companies – such as AgroGene, CropDesign, Meristem,
Biogemma, and Metanomics – continue this innovative tradition,
albeit at a lower pace than in the USA.
European companies – such as Bayer, BASF and Syngenta, which are
among the world’s top six agribusinesses – have committed
significant funding to strategic research in crop biotechnology
and genomics. They have also developed, either in house or
through collaborations, key technologies for particular crops
and methodologies. The EU seed sector has major players
including Limagrain, Advanta, KWS and DLF-Trifolium. Europe
hosts two of the top four global food companies. Unilever and
Nestlé have strong product development expertise and experience
in a diverse set of crops and products. They also have a
tradition of research in plant sciences and have followed the
evolution of plant genomics and biotechnology.
Falling behind
European investment in plant genomics and biotechnology has
stalled in recent years. This is partly as a result of a more
restrictive political and regulatory framework compared with
that of its major competitors in the USA, Japan and China.
European biotech SMEs are increasingly turning to non-EU
customers, while firms of all sizes are relocating their
research activities and investments to these three countries,
and even India and Argentina. These countries have a long-term
strategy for exploiting the potential of plant genomics and
strengthening their positions in related markets. The USA and
Japan, in particular, are developing forward-looking policies to
forge for themselves a leading position in the emerging
biomaterials and bio-energy markets. Europe risks losing out on
its investment in plant genomics and biotechnology as the
exploitation of its science and technology base will
increasingly be done outside the EU.
The huge potential of plant genetic diversity can only be
unlocked through sustained investment in research. While US
biotech firms spend €650 million a year on R&D, their EU
counterparts invest only €400 million. Last year, the American
government launched a National Plant Genome Initiative with a
total budget of €1.1 billion from 2003 to 2008. EU15 support is
estimated to be around €80 million annually. In addition, strict
European health and safety regulations have shifted popular
resistance from health concerns to the potential environmental
impact of the release and use of GM crops. In the meantime,
global use of these plants is on the rise, with 99.5% grown
outside the EU.
What is at stake for Europe?
European industry, consumers and farmers will all be affected by
the emerging plant genomics and biotechnology innovation gap
between the EU and its main global competitors. As a recent
study showed, the impact on Europe’s science and technology base
is already considerable: 27% of European research projects in
this area have been aborted in recent years and, for industry,
the figure was a massive 63%. New GM-derived products will be
allowed to enter the European market soon. Further market
development will depend on whether European retailers and
consumers will consider the potential benefits in terms of price
and improved quality outweigh the hypothetical risks. This in
turn will affect more than 15 millions European farms in 25
Member States and the European food industry, in particular the
large number of SMEs which account for half of the industry’s
output and three-fifths of its workers.
In a scenario where EU agricultural output is less
technologically competitive, European farmers will likely find
that their shrinking share of conventional and GM markets will
not be offset by the growth of alternative niches, such as the
organic food market. Fierce global price competition may also
lead to a shift from European products to imports that may be
less diverse. Although imports can be and are beneficial, this
may limit the range of EU consumer lifestyle and health choices.
This might lead to pressure for more EU agricultural subsidies,
although the EU is attempting to scale back such aid.
The deterioration of the EU’s scientific base, the loss of
markets for European agricultural products and an increased
dependence on food and feed imports are at stake. Europe’s
ability to respond to the policy challenges of sustainable
agriculture and to secure global food supply may diminish. This
could also severely restrict European industry’s ability to
contribute to non-food agricultural innovations and a bio-based
economy. Twenty years from now, European consumers are at risk
of being left with the limited choice of buying local products
at much higher prices or cheaper imports. Although imports are
essential to economic efficiency, fair competition and consumer
choice, allowing agricultural imports to rise above a certain
level may leave Europe vulnerable or, at least, dependent on
produce in which the incorporated technology reflects very
different cultural, scientific and lifestyle priorities. The
question is whether Europe will facilitate the careful
development of plant genomics and biotechnology within the EU to
reflect the Union’s high standards in new product design.
Eliminating a costly paradox
Europe cannot afford to miss out on the benefits offered by
plant genomics and biotechnology. Justified environmental and
health concerns have to be balanced against tolerable risks,
likely economic impacts and employing the new technology to help
respond to major social and environmental challenges. A
technology platform, such as the one proposed in this document,
can help refine the R&D regulatory and policy framework to make
the most of these new technologies for the prosperity and well
being of Europe’s citizens, economy and environment. This
requires concerted action on the part of all stakeholders,
including researchers, farmers, industry, consumers, regulators
and policy-makers.
Open, frank and balanced public dialogue on such a sensitive
issue will not be an easy task. But the pay off for sharing and
acting upon a common vision can be enormous. Europeans owe it to
themselves and future generations to build a scientifically
solid and ethically sound foundation for developing this
exciting field.
CHAPTER 3 - A VISION FOR
2025
Food trends and challenges
Europe, like other developed countries, is facing the challenges
linked to changing lifestyles and an ageing population. Rising
living standards and an abundance of food have pushed obesity
and heart disease up the list of avoidable deaths in the
industrialised world. As Europeans continue to enjoy longer and
more comfortable lives, the importance of food quality and
safety will increase enormously over the next two decades.
Access to a wide variety of healthy and affordable high quality
food will help ensure this. In addition, safe food production is
not only about human health but must take into account the
health of cattle and other animals, as recent food scares have
so clearly illustrated.
·
Changing lifestyles
Improvements in medical science and health care have meant that
people in Europe and other developed countries live longer and
healthier lives. These advances have also meant that lifestyle
choices are playing an increasingly decisive role in our
well-being. While the burning issue of smoking is being brought
gradually under control, poor diets are claiming more and more
lives in Europe and other rich countries. The need to increase
the nutritional value of food products and encourage healthy
dietary choices is an important component in reducing heart
disease, cancer and obesity, which are becoming the biggest
causes of avoidable deaths in developed countries.
·
Greying societies
Slowing birth rates and longer life expectancy in Europe, Japan
and the United States have led to a rapidly ageing population –
if present trends continue, there may be more people over 60
than children by 2025. There is also a fast growing awareness
among the citizens of these same countries of the health
problems associated with eating habits. In fact, the older
people get, the more important a balanced and healthy diet
becomes. The right balance of food can reduce a person’s risk of
suffering from a heart attack, a stroke, and even cancer. The
agricultural and food industries have a unique opportunity to
contribute to solving these problems through improving the
health promoting properties of crops and derivative food
products.
·
Global demographics
There are some 6 billion people in the world today. Despite
declining rates of population growth, the global population is
increasing by about 80 million a year – equivalent to the
population of Germany – and is projected by the UN to reach 9
billion by 2050. Around 95% of this increase is taking place in
the developing world and not in Europe. To be able to feed all
these unborn mouths, new and sustainable ways of producing high
quality food and feed must be developed. In addition, the world
needs to produce more food but, just as importantly, the
international community needs to develop the political
mechanisms to guarantee that it gets to the people who need it.
High economic growth rates in developing countries have
significantly raised living standards there. The
most spectacular change has occurred in Southeast Asia and,
specifically, in China. However, societies in Europe and North
America are also becoming richer, albeit at a slower pace. With
more people who are richer and older to sustain than ever
before, the demand for high quality and varied food will spiral
in the coming years.
Sustainability – a means and an end
·
Environmental concerns
In recent decades, European citizens have become more aware of
their environment and exhibit a growing concern about the
countryside and its biodiversity. European citizens are becoming
more vocal in their calls for action to protect the environment,
maintain biodiversity and conserve natural resources, especially
soil and water.
Europe has a diverse countryside, especially when compared with
the vast farming regions in the Americas where hundreds – even
thousands – of square kilometres of farmland might be given over
to one crop. Centuries of local agricultural, woodland and
forest management have led to a great deal of regional variation
across Europe.
Over the past two centuries, industrialisation has led to the
growth of large cities where, in many EU Member States, the
majority of citizens now live and work. Nevertheless, this has
not reduced the importance of rural areas. In addition to
producing food, the countryside forms a key component of
European cultural heritage.
As agricultural practices have changed so has the countryside
and the biodiversity it supports. The productivity of European
land has risen dramatically over the past 50 years. However,
modern farming techniques, along with urbanisation, have left
their toll on rural biodiversity. Global warming is causing a
change in the distribution of plant pathogens and pests. This
will lead to new challenges in developing plants that are
resistant to diseases, pests and more volatile weather systems.
It is also important to strike the right land management
equilibrium, both in terms of the varieties of plants and how
they are grown.
·
Sustainable industrial processes
Within Europe, the development, establishment and increase in
industrial production over the past two centuries has resulted
in a number of environmental concerns. These include climate
change which is potentially exacerbated by rising greenhouse gas
emissions. The quality of the air we breathe, the water we drink
and the soil in which we plant are all directly or indirectly
affected by industrial processes and their by-products.
The production of bioenergy, biofuels and novel biomaterials is
not yet common but it offers great opportunities to move towards
a sustainable bio-based economy. It can also help boost rural
development by enabling local communities to participate in the
value creation chain.
·
Energetic future
In the first two decades of the 21st century, world
energy consumption is expected to rise by more than 50%. A major
share of that growth is expected to occur in developing
countries – especially in Asia and Central and South America –
where energy demand could rise at a rate of about 4% a year. A
large number of independent projections forecast that this
increased energy usage will lead to serious global warming.
Although the EU puts much greater emphasis on other sustainable
energy sources, in principle, plants can contribute in two ways
to solving the energy problem. On the one hand, the direct
combustion of plants results in a five-fold net energy gain in
terms of the input/output ratio. However, converting the plant
into liquid biofuels currently results in a loss of energy.
Improving plants by making the conversion process less
energy-intensive represents a useful line of attack for future
research. Despite the challenges ahead, developing more
efficient biofuels is a worthwhile pursuit because plants have
no impact on the carbon dioxide balance. How much Europe can
depend on biofuels to meet its energy needs will depend on how
far the technology to extract them advances and the amount of
available land left over from other, higher priority functions.
·
Loss of land
The world's agricultural land is being degraded. In fact, arable
land is losing its fertility owing to salination,
desertification, as well as soil erosion and nutrient depletion.
The maintenance of common property – including rangelands,
fisheries, forests and genetic resources – is under increasing
pressure owing to the pressure of population growth. Rapid
urbanisation and the need to produce more food mean that huge
areas of natural forest are being deforested, leading to more
soil erosion and flooding. Meeting the growing demand for food
and plant-derived products will become even more challenging as
this is accompanied by a decrease in the global arable land
base.
Competitive research policy
Europe’s scientific heritage and culture provides a unique opportunity
for global economic leadership in the emerging knowledge-based
economy. The EU’s cultural and scientific diversity will provide
it with a key advantage over its global competitors. Although
farming has a quaint and rustic image, agriculture is rapidly
turning into one of the most high-tech sectors of the economy.
Here, too, Europe’s diversity gives it a competitive edge.
There is a high degree of regional agro-ecological variety in the EU.
There are also big differences in the economics of the
agricultural sector – from the degree of farming automation to
the importance of local agricultural service industries. This
diversity is well reflected in the great variety of food and
feed used in Member States. This is in sharp contrast with the
situation in some parts of the United States, Argentina and
Brazil where vast tracts of land are used to grow just a few
crops, particularly maize and soybean.
The long tradition of European innovation, coupled with the
diverse crop types and production methodologies, provides Europe
with a good opportunity to develop a larger number of crop types
that not only perform well across a wide area of climatic zones,
but are also able to meet special needs on a regional basis.
In order to maintain its prosperity and autonomy, Europe needs
to remain competitive. Competitiveness is not simply limited to
basic research, but extends across the board: R&D, field
production, and end-product applications.
Coherent policy framework
In order to enhance its competitiveness, the EU must develop and
establish a long-term holistic and coherent policy for plant
genomics, biotechnology, and their applications. Through a broad
dialogue, it must develop and set in place the necessary policy
delivery tools that will enable the EU to carry out high quality
R&D. The first step towards forging such a coherent framework
would be, as mentioned earlier, to establish the Plants for
the Future platform which can help chart a road map for
action.
Regulation is essential as it protects the citizens against
exploitation and ensures a level playing field for businesses.
The wrong mix of regulations can leave innovators bound up in
red tape. The right mix and it rolls out the red carpet for
them. Although the regulatory arena in Europe is complex,
regulation itself plays a crucial role in supporting basic
research and the application of knowledge.
If the EU is to participate in and benefit from research into
plant genomics and biotechnology (and from the resulting
products), then regulatory frameworks must be carefully
considered and developed in a cohesive and inclusive manner.
This also implies better communication with the public, i.e.
regarding the results of risk assessments. European regulation
must be consistent in design and operation and be transparent
both to the European citizenry that it is established to
benefit, and to the research and industry sectors whose
activities are being regulated.
As an example of the importance of consistent and fair
implementation of regulation, the EU now has a comprehensive
framework in place for the safety assessment and placing on the
market of GM crop plant varieties – although co-existence is
still an issue of debate. If EU institutions and Member States
fail to implement this legislation consistently and
transparently, the present reluctance of both the public and
private sectors to invest in biotech R&D will remain – and the
broad objectives set out in this paper will be unattainable.
The right blend of regulations could lead to massive
improvements in our quality of life and its sustainability.
Below is a vision of what new knowledge generated by European
research could potentially lead to over the next two decades.
Ambitious research agenda (2005-2025)
Research into plant genomics – handled with appropriate
caution and public support – can result in major benefits for
Europeans over the coming two decades. Through well-targeted
basic research into plant genomics and its biotechnological
applications, we believe it is possible to:
Improve understanding of plant metabolisms
Basic research can enhance our understanding of metabolic
pathways in plants and how these pathways are affected by
environmental conditions. It can also help cast light on
photosynthesis, plant architecture, sink-source distribution
of energy and other plant development factors. In addition to
furthering the human quest for knowledge, this improved
understanding could potentially pay enormous dividends in
terms of health, the environment, and industrial yields.
Secure a healthy, high quality food/feed supply
This can be achieved by, for example, developing plants
containing more essential macro and micro-nutrients
(carbohydrates, starch, essential fatty acids, oils, vitamins,
amino acids, antioxidants, fibres, etc), and that result in
end products with less natural contamination from fungal
mycotoxins, anti-nutritional compounds and environmental
pollutants.
Improve plant yield potential and security
These two important goals will help ensure global food
security by ensuring we can produce enough to feed a growing
world population. This can be tackled from two angles:
increasing land productivity and reducing crop losses caused
by disease and volatile weather patterns. Increases in
productivity – particularly of marginal land – will provide a
wider range of choices in countryside management. Research
into plant genomics can help boost crop yields without the
need for chemical fertilisers and make plants more resilient
to fungal infections, viruses, insects and other blights, as
well as abiotic stress and toxic compounds in soil. It can
also help improve the harvestability, storability and
processability of crops. This will help prevent the massive
losses that occur during the food/feed processing chain.
Increase the amount of useful plant matter
This can be achieved by developing plants that – after
harvesting, transportation, storage and processing – provide
the maximum quantity of desired end products (i.e.
metabolites).
Improve countryside biodiversity
This can be done by developing plants that can be grown with
reduced cultivation, inputs and end product processing. This
would help prevent soil erosion and reduce the use of
agricultural inputs, energy and water.
Improve the genetic diversity
of crop plants
Agriculture has only just scratched the genetic surface of
plants. Research into plant genomics can help expand the
variety of crops we cultivate. This will give us access to new
types of food with all that implies in terms of taste and
nutrition.
Reduce the environmental impact of agriculture
This can be done by developing plant varieties that need less
fertilizer, water and other agro-chemical inputs while
producing the same high yields.
Enhance crop monitoring
Research into plant genomics can also help farmers to monitor
their crops more effectively. Better knowledge of the
molecular mechanics of plants will enable scientists to
develop tools – such as agro-climatic models integrating
genetic data – to forecast crop performance and detect
problems early on. By reducing waste and providing an early
warning system, such tools will help reduce the impact of
agriculture on the environment and to improve crop quality.
Improve crop co-existence
To ensure consumer and farmer choice, GM, conventional and
organic crops will need to exist side by side. This can be
achieved in a number of ways, such as applying appropriate
agricultural practices and cultivating GM plants containing
biological characteristics that reduce gene flow. These
include engineering cleistogamy (which prevents plants from
pollinating) or cytoplasmic male sterility into ‘specialty’
crops so that they retain the purity of their special features
without running the risk of mixing with other plants.
Develop renewable materials
This can be achieved by developing plant types that can be
grown as sources of renewable materials. This will help cut
down on the fossil energy used and waste currently generated
in producing them. Examples include plants developed to
produce biopolymers, such as biodegradable plastics.
Develop more efficient biofuels
This ambitious goal can be reached by increasing the variety
of plants that contribute to the renewable resource base,
improving the conversion process for plants that are currently
used as biofuels, and developing new plant types that produce
oils which can be used efficiently as an energy source and
could also be used in food packaging.
CHAPTER 4 - THE WAY
FORWARD
As this document has highlighted, the potential of plant
genomics and biotechnology to deliver major advances in our
lifestyles and prosperity is enormous. It can also maintain and
enhance the competitiveness of EU farmers and food producers. In
order for this bright future to materialise, the EU and its
Member States need to take action now. Towards this end, we
recommend the creation of a new technology platform to take the
first steps towards building a consensus on the way forward. It
will also help to set and coordinate the EU research agenda in
the field. To get the ball rolling, we propose that the
Plants for the Future
platform be constructed on the following basis.
Strategic priorities
Europe’s main short, medium and long-term plant genomics and
biotechnological research objectives, as laid out in this
document could constitute part of Plants for the Future’s
priorities – the others to be set in debates with the various
stakeholders. The platform should focus on improving the safe
exploitation of the genetic diversity in plants to:
·
Produce better quality, healthy, affordable, diverse food
offering consumers in and beyond Europe real options to improve
their quality of life.
·
Bring about environmental and agricultural sustainability,
including biomaterials, bioenergy and renewable resources
·
Enhance the competitiveness of European agriculture, industry
and forestry
Main activities
To meet its strategic priorities,
Plants for the Future
should focus on:
·
Developing and implementing a pertinent long-term research
agenda
based on the identification of the priorities of the sector and
of European citizens. We estimate that public and private
funding – at EU, national and regional level – will have to
exceed €45 billion over the next ten years if Europe is to
remain competitive
·
Enhancing the transparency of the R&D effort at the
regional, national and European levels
·
Promoting a coherent policy and supportive regulatory
environment
·
Addressing public concerns and developing societal
consensus based on a mutual understanding between all
stakeholders
Management
structure
The Plants for the Future technology platform will be
managed by the Advisory Council, which will be set up to turn
the current patchwork of plant genomics and biotechnological
research into a coordinated, well-supported research network. To
do so, it will define the contents of the Strategic Research
Agenda and attract the necessary funding to implement it.
The Advisory Council should actively link the platform with all
stakeholders, pooling ideas and fostering support for it. The
Advisory Council must, therefore, be a broad representation of
all the parties which have a stake in this crucial sector,
including scientists, industry, consumer and farmers groups,
environmental organisations, regulatory bodies, as well as
political decision- and policy-makers at the EU, national and
regional levels. These partners need to co-operate pragmatically
to identify priorities.
Road map and milestones
The Plants for the Future platform should promote
basic research in the field of plant genomics and biotechnology.
It should focus on EU-grown crops, develop applied research
programmes in the agro-food domain, and launch novel
product-oriented R&D projects. We recommend the following
research milestones on the road map to improving the sector.
Short and medium-term (to 2015)
-
Establish coherent basic plant genomics research programmes
for the major EU-grown crops: cereals, grain legumes,
solanaceous species, major oil producing plants, and fruit and
wood-producing trees
-
Develop research programmes aimed at exploiting the knowledge
from plant genomics and biotechnology to improve the
sustainability of production, co-existence, yield,
harvestability, storability and processability of the major
EU-grown crops
-
Develop research programmes focused on the nutritional
contents of food and feed crops
-
Establish public/private partnerships to explore the
development of novel agricultural, food, energy and
biomaterials products
In the medium and long-term (to 2025)
-
Develop a comprehensive genomics knowledge base for all
economically and strategically important crops grown in the EU
and their related genetic resources
-
Develop enhanced phenotyping tools for mining the genetic
diversity of important EU crops
-
Establish public/private partnerships to develop superior crop
varieties which meet the requirements for sustainable
production in an environmentally friendly manner, while
satisfying consumer preference for healthy and safe food
-
Establish collaborative programmes with developing countries
on crop genomics to promote self-sufficiency, greater
sustainability and competitiveness there
The
Plants for the Future platform’s goal should be to involve
all stakeholders in the accompanying activities and, in
particular, to translate the strategic priorities defined above
into a coherent and dynamic research agenda. The Advisory
Council will be managed in a way that will encourage initiatives
in a bottom-up and realistic way. We plan to create the Advisory
Council by mid-2004 which will then formulate a strategic agenda
by early-2005.
Plants for the Future
should make use of available EU instruments, and promote the
networking and coordination of national programs as exemplified
by the ERA-NET initiative. For the first time, this ERA-PG (for
plant genomics) brings together research programme-makers and
managers from across Europe to improve the coordination of
national and regional plant genomics research programmes. It
will also identify and support actions of specific importance at
the regional level and complement these activities with
private-public partnerships.
To be successful in the long-term, this initiative needs to be
transparent and forge a reasonable consensus at the level of the
Advisory Council. It should include the critical evaluation of
novel developments, regardless of whether they are positive or
appear questionable. It will also be crucial to create the legal
framework necessary to exploit the results of the research
programme. This platform will help Europe reap the rewards of an
invigorated agro-industry sector delivering a large diversity of
safe and healthy food and bio-products.
SELECTED GLOSSARY
Agri-food sector:
the sector of the economy that produces agricultural and
food products
Agribusiness:
agriculture-related industries
Agro-food industry:
agriculture and food related industries
Bio-based economy:
the
sector of the economy that produces products derived from living
organisms
Biofuels:
fuels derived from living organisms, as opposed to fossil fuels
Biomaterials:
materials derived from living organisms, as opposed to synthetic
materials
Biotechnology:
technologies for cultivating, modifying or deriving products
from living organisms
Co-existence:
the cultivating of conventional, organic and genetically
modified crops in the same area without them affecting one
another
Conventional food:
food as we find it in our shops, i.e. using contemporary
agricultural and manufacturing practices –not organic nor
genetically modified food
Genetics:
science and technology of hereditary factors
Genetic modification:
scientific
technique for altering the genetic make up of living organisms
which results in genetically modified organisms (GMOs)
Genetically modified food:
food obtained from genetically modified organisms (GMOs)
Forestry:
the
cultivation of trees and the management of forests and woodland.
Related sectors include paper and pulp industry.
Organic food:
food obtained without the use of chemicals
Plant genomics:
the
science and technology of the genetic make up of plants
GENVAL GROUP
The Genval Group – which was set up by the European Association
for Bioindustries (EuropaBio) and the European Plant Science
Organisation (EPSO), in co-operation with the Commission in 2003
to draft this document – is made up of:
Simon Barber (EuropaBio) Indridi
Benediktsson (European Commission)
Simon Bright (Syngenta, UK) Michel
Caboche (INRA, FR)
Bernard Convent (Bayer, BE) Dick
Flavell (Ceres, US)
Hans Kast (BASF, DE) Beate
Kettlitz (BEUC)
Waldemar Kütt (European Commission) Markwart Kunz
(Südzucker, DE)
Chris Lamb (JIC, UK) Etienne
Magnien (European Commission)
Karin Metzlaff (EPSO) Jim
Murray (BEUC)
Christian Patermann (European Commission) Vincent Pétiard
(Nestle, FR/CIAA)
Christophe Roturier (ARVALIS, FR) Joachim
Schiemann (Federal Biological Research Centre, DE)
Ralf-Michael Schmidt (BASF) Lothar
Willmitzer (MPIMP, DE)
Frank Wolter (ESA, DE) Marc
Zabeau (VIB, BE)
|